PREVENTION OF PERIOPERATIVE COMPLICATIONS IN CHILDREN WITH CONGENITAL UROPATHIES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. To substantiate the expediency of immunomodulators and probiotics application pathogenetically in the comprehensive preoperative preparation in children with congenital uropathies (ОТ). Materials and methods. The study includes 60 patients with various types of congenital uropathy (CU) (vesicoureteral reflux, hydronephrosis, obstructive ureterohydronephrosis), which were divided into 3 groups in accordance with the preoperative preparation complex. 1 group - 20 patients with VU, immunomodulating drug Kipferon was added to the therapy at the preoperative stage, group 2 - 20 patients with VU - with the addition of the biologically active additive (BAA) «Bifidum №791 BAG», 3 control group - 20 children with VU standard complex of preoperative preparation. The diagnosis of VU was established using a standard urological examination. The examination of the content of pro-(IL-8) and anti-inflammatory (IL-10) cytokines in the urine was performed before the start of treatment (1 point) and on the 3-5th day after surgery (2 point) for all patients using the method of enzyme-linked immunosorbent assay. Results. Based on signs of systemic inflammation and urinary syndrome, initially patients of all groups (n=60) were in the latent phase of chronic obstructive pyelonephritis. After surgical correction pyelonephritis was diagnosed in all children at point 2, the most pronounced was in the control group. Manifestation of dysbiosis in the control group was more often by 20% than in group 2. The examination of the cytokine profile of urine showed an increasing the level of IL-8 (p<0.0001) at 2 points in all groups, the most significant was in the control group (p<0.002). An increasing the level of IL-10 (p<0.0001) was noted at point 2 in all groups, the most significant was in groups 1 and 2 (p<0.003). High values of the inflammation activity index were observed only at point 2 in the children of the control group (p<0.001). Conclusion. The using of immunomodulators and probiotics in the comprehensive preoperative preparation of children with obstructive uropathies reduces the risk, severity and duration of postoperative complications.

Full Text

Restricted Access

About the authors

O. L Morozova

Sechenov First Moscow State Medical University

Email: morozova_ol@list.ru
MD, professor at the Department of Pathophysiology Moscow, Russia

D. A Morozov

Sechenov First Moscow State Medical University

Email: damorozov@list.ru
MD, professor at the Department of Pediatric Surgery, Urology and Andrology Moscow, Russia

D. Y Lakomova

Saratov State Medical University n. a. V.I. Razumovsky

Email: dlmedic@mail.ru
Ph.D., assistant at the Department of Pediatric Surgery Saratov, Russia

L. D Maltseva

Sechenov First Moscow State Medical University

Email: lamapost@mail.ru
Ph.D., associate professor at the Department of Pathophysiology Moscow, Russia

D. D Morozov

Sechenov First Moscow State Medical University

Email: mr.morozovy@mail.ru
student of International school “Medicine of the Future” Moscow, Russia

References

  1. Yilmaz І., Peru H., Yilmaz F.H., Sekmenli T., Çiftçi 1., Kara F. Association of vesicoureteral reflux and renal scarringin urinary tract infections. Arch Argent Pediatr 2018;116(4):e542-e547. doi: 10.5546/aap.2018.eng.e542.
  2. Esposito C., Masieri L., Blanc T., Manzoni G., Silay S., Escolino M. Robot-assisted laparoscopic pyeloplasty (RALP) in children with horseshoe kidneys: results of a multicentric study. World J Urol. 2019 Jan 14. doi: 10.1007/s00345-019-02632-x.
  3. Vahlensieck W., Friess D., Fabry W., Waidelich R., Bschleipfer T. Longterm results after acute therapy of obstructive pyelonephritis. Urol Int. 2015;94(4):436-441. doi: 10.1159/000368051.
  4. Edwards A., Peters C.A. Managing vesicoureteral reflux in children: making sense of all the data. F1000Res. 2019 Jan 8;8. pii: F1000 Faculty Rev-29. doi: 10.12688/f1000research.16534.1.
  5. Balasubramanian S., Kuppuswamy D., Padmanabhan S., Chandramohan V., Amperayani S. Extended-spectrum Beta-lactamase-producing Community-acquired Urinary Tract Infections in Children: Chart Review of Risk Factors. J Glob Infect Dis. 2018;10(4):222-225. doi: 10.4103/0974-777X.246391.
  6. Khan A., Jhaveri R., Seed P.C., Arshad M. Update on Associated Risk Factors, Diagnosis, and Management of Recurrent Urinary Tract Infections in Children. J Pediatric Infect Dis Soc. 2018 Jul 23. doi: 10.1093/jpids/ piy065.
  7. Selekman R.E., Shapiro D.J., Boscardin J., Williams G., Craig J.C., Brandström P., Pennesi M., Roussey-Kesler G., Hari P., Copp H.L. Uropathogen Resistance and Antibiotic Prophylaxis: A Meta-analysis. Pediatrics. 2018l;142(1). pii: e20180119. doi: 10.1542/peds.2018-0119.
  8. Whiteside S.A., Dave S., Seney S.L., Wang P., Reid G., Burton J.P. Enterococcus faecalis persistence in pediatric patients treated with antibiotic prophylaxis for recurrent urinary tract infections. Future Microbiol. 2018;13:1095-1115. doi: 10.2217/fmb-2018-0048.
  9. Kline K.A., Lewis A.L., Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract Microbiol Spectr. 2016;4(2):10.1128/microbiolspec.UTI-0012-2012.
  10. Aeddula N.R., Baradhi K.M. Reflux Nephropathy. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018.
  11. Small A.C., Perez A., Radhakrishnan J., Desire S., Zachariah P., CreelmanL.C., Alam S. Impact of positive preoperative urine cultures before pediatric lower urinary tract reconstructive surgery. Pediatr Surg Int. 2018;34(9):983-989. doi: 10.1007/s00383-018-4306-5.
  12. Habibi M., Asadi Karam M.R., Bouzari S. Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection. Microb Pathog. 2018;117:348-355. Doi: 10.1016/j. micpath.2018.02.023.
  13. Ghouri F., Hollywood A., Ryan K. A systematic review of non-antibiotic measures for the prevention of urinary tract infections in pregnancy. BMC Pregnancy Childbirth. 2018;18(1):99. doi: 10.1186/s12884-018-1732-2.
  14. LauG., Anderson R., Cartwright P., Wallis M.C., Schaeffer A., Oottamasathien S., Snow B. Unilateral open extravesical ureteral reimplanation with contralateral dextronomer/hyaluronic acid injection performed as an outpatient therapy. J Pediatr Urol. 201;14(6):566.e1-566.e5. Doi: 10.1016/j. jpurol.2018.07.014. Epub 2018 Jul 25.
  15. Serena G., Fasano A. Use of Probiotics to Prevent Celiac Disease and IBD in Pediatrics. Adv Exp Med Biol. 2018. doi: 10.1007/5584_2018_317.
  16. Kasatpibal N., Whitney J.D., Saokaew S., Kengkla K., Heitkemper M.M., Apisarnthanarak A. Effectiveness of Probiotic, Prebiotic, and Synbiotic Therapies in Reducing Postoperative Complications: A Systematic Review and Network Meta-analysis. Clin. Infect. Dis. 2017;64:S153-S160. doi: 10.1093/cid/cix114.
  17. Plaza-Diaz J., Ruiz-Ojeda F.J., Gil-Campos M., Gil A. Mechanisms of Action of Probiotics. Adv Nutr. 2019;10(suppl_1):S49-S66. Doi: 10.1093/ advances/nmy063.
  18. Swartwout B., Luo X.M. Implications of Probiotics on the Maternal-Neonatal Interface: Gut Microbiota, Immunomodulation, and Autoimmunity. Front Immunol. 2018;9:2840. doi: 10.3389/fimmu.2018.02840.
  19. Suez J., Zmora N., Zilberman-Schapira G., Mor U., Dori-Bachash M., Bashiardes S., Zur M., Regev-Lehavi D., Ben-Zeev Brik R., Federici S., et al. Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT. Cell. 2018;174:1406-1423. e16. doi: 10.1016/j.cell.2018.08.047.
  20. Bone R.C., Grodzin C.J., Balk R.A. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997; 112(1):235-243. Doi:10.1378/ chest.112.1.235
  21. Jayaweera JAAS., Reyes M. Antimicrobial misuse in pediatric urinary tract infections: recurrences and renal scarring. Ann Clin Microbiol Antimicrob. 2018;17(1):27. doi: 10.1186/s12941-018-0279-4.
  22. Liao H.Y., Tao L., Zhao J., Qin J., Zeng G.C., Cai S.W., Li Y., Zhang J., Chen H.G. Clostridium butyricum in combination with specific immunotherapy converts antigen-specific B cells to regulatory B cells in asthmatic patients. Sci Rep. 2016;6:20481. doi: 10.1038/srep20481.
  23. Skonieczna-Zydecka K., Kaczmarczyk M., Loniewski I., Lara L.F., Koulaouzidis A., Misera A., Maciejewska D., Marlicz W. A Systematic Review, Meta-Analysis, and Meta-Regression Evaluating the Efficacy and Mechanisms of Action of Probiotics and Synbiotics in the Prevention of Surgical Site Infections and Surgery-Related Complications. J Clin Med. 2018;7(12). pii: E556. doi: 10.3390/jcm7120556.
  24. Haase S., Haghikia A., Wilck N., Muller D., Linker R. Impacts of microbiome metabolites on immune regulation and autoimmunity. Immunology. 2018;154:230-238. doi: 10.1111/imm.12933.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies